Conexiant
Login
  • Corneal Physician
  • Glaucoma Physician
  • New Retinal Physician
  • Ophthalmology Management
  • Ophthalmic Professional
  • Presbyopia Physician
  • Retinal Physician
The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Issues / 2025 / May / Also in the News… (7)
Glaucoma Cornea Retina Refractive Professional Development

Also in the News…

From novel markers for presbyopia to new findings on diabetic retinopathy severity, these are the news stories and studies that caught our attention this week…

By Alun Evans 5/9/2025 2 min read

Share

0525-000-Online-Week2.png

Tomwsulcer, CC0, via Wikimedia Commons

Novel marker for Accommodative Effort in Presbyopes. CooperVision and the University of Rochester Flaum Eye Institute team have identified a novel OCT-based marker for presbyopic accommodation. The presentation was made at the ARVO 2025 Annual Meeting on Wednesday, May 7. Link

Cascader launch. The UCL Institute of Ophthalmology (IoO), Moorfields Eye Hospital, and Topcon Healthcare have launched medical technology company, Cascader Limited. "Cascader is uniquely positioned at the intersection of clinical excellence, academic leadership, and technological innovation,” says Moorfields consultant ophthalmologist, professor of artificial medical intelligence at UCL IoO, and Cascader co-founder, Pearse Keane. “We are building on more than a decade of research into AI and Oculomics - fields in which we’ve been proud to lead globally - and are now focused on delivering those discoveries into everyday clinical care. Link

Potential new therapy for Alzheimer’s Disease. A new Disease Models & Mechanisms study has investigated how glucose metabolism in glial cells influences neurodegeneration in a Drosophila (fruit fly) model of Alzheimer’s disease. The Tokyo-based researchers found that expressing human Tau protein in fly retinal cells led to neurodegeneration marked by inflammation and glial abnormalities. Enhancing glucose uptake specifically in pigment glial cells significantly reduced inflammation, inclusion formation, and photoreceptor degeneration. Link

Links between DR Severity and diabetes diagnosis age. A Scientific Reports study has investigated the relationship between age at diabetes diagnosis (ADD) and the risk and severity of diabetic retinopathy (DR). Using data gathered from the National Health and Nutrition Examination Survey (NHANES) database, the researchers – based at The Second Affiliated Hospital of Chongqing Medical University, China – found that younger ADD was significantly associated with a higher risk and greater severity of DR. Genetic analysis confirmed a likely causal relationship, highlighting the importance of early screening and intensive management for individuals diagnosed with diabetes at a younger age​. Link

About the Author(s)

Alun Evans

More Articles by Alun Evans

Related Content

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: